Neurocrine Biosciences (NBIX) Assets (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Assets of $5.4 billion for Q2 2026, up 37.77% year-over-year from $3.9 billion in Q2 2025, and up 9.23% on a QoQ basis from $4.9 billion in Q1 2026.
Neurocrine Biosciences (NBIX) Assets (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Assets for 17 years, with the latest figure at $5.4 billion in Q2 2026.
- Assets for Q2 2026 came in at $5.4 billion, up 37.77% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.4 billion (up 37.77% YoY), and the FY2025 annual result was $4.6 billion, up 24.55% from the prior year.
- Assets grew to $5.4 billion in Q2 2026, from $4.9 billion in the prior quarter.
- Over five years, Assets peaked at $5.4 billion in Q2 2026 and troughed at $2.0 billion in Q2 2022.
- A 5-year average of $3.4 billion and a median of $3.4 billion in 2024 frame the typical range for Assets.
- The widest annual swing landed in 2022, when Assets rose 2.52%; it then soared 47.15% in 2024.
- A 5-year view of Assets shows it stood at $2.4 billion in 2022, then soared by 37.27% to $3.3 billion in 2023, then gained by 14.37% to $3.7 billion in 2024, then increased by 24.55% to $4.6 billion in 2025, then climbed by 15.71% to $5.4 billion in 2026.
- Per Business Quant data, the three most recent Assets figures were $5.4 billion in Q2 2026, $4.9 billion in Q1 2026, and $4.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 6.18 Bn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 4.39 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.36 Bn |
| Mar 31, 2026 | 4.91 Bn |
| Dec 31, 2025 | 4.63 Bn |
| Sep 30, 2025 | 4.27 Bn |
| Jun 30, 2025 | 3.89 Bn |
| Mar 31, 2025 | 3.69 Bn |
| Dec 31, 2024 | 3.72 Bn |
| Sep 30, 2024 | 3.54 Bn |
| Jun 30, 2024 | 3.31 Bn |
| Mar 31, 2024 | 3.47 Bn |
| Dec 31, 2023 | 3.25 Bn |
| Sep 30, 2023 | 2.85 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | 2.36 Bn |
| Dec 31, 2022 | 2.37 Bn |
| Sep 30, 2022 | 2.14 Bn |
| Jun 30, 2022 | 2.01 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Dec 31, 2021 | 2.07 Bn |
| Sep 30, 2021 | 2.02 Bn |